LifeStance Health Group, Inc. (LFST)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 39.38%: Here's is How to Trade
The mean of analysts' price targets for LifeStance Health (LFST) points to a 39.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
LifeStance Health Group, Inc. (LFST) Q2 2024 Earnings Call Transcript
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Monica Prokocki - Vice President of Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JPMorgan Jack Senft - William Blair Dylan Finley - UBS Jack Slevin - Jefferies Stephanie Davis - Barclays Operator Thank you for standing by. My name is Jermanie, and I will be your conference operator today.
LifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates
LifeStance Health Group (LFST) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.13 per share a year ago.
Lost Money on LifeStance Health Group, Inc.(LFST)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
Shareholders that lost money on LifeStance Health Group, Inc.(LFST) should contact Levi & Korsinsky about Securities Fraud Investigation - LFST
NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
An Investigation Has Commenced on Behalf of LifeStance Health Group, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your LFST Losses
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
LifeStance Health Group (LFST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
LifeStance Health (LFST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lost Money on LifeStance Health Group, Inc. (LFST)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
ATTENTION LFST SHAREHOLDERS: Investors who lost money on LifeStance Health Group, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
Does LifeStance Health (LFST) Have the Potential to Rally 54.84% as Wall Street Analysts Expect?
The mean of analysts' price targets for LifeStance Health (LFST) points to a 54.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The Schall Law Firm Examines LifeStance Health Group Inc And Urges Impacted Investors To Engage In Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Examines LifeStance Health Group Inc And Urges Impacted Investors To Engage In Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
